Streetbeat News

Products Services

TSLA

ZAPP

Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) shares are down 2.2% on heavy trading volume, with over 16.5 million shares traded in the session, compared to the 100-day average of less than 108 thousand shares. This could be driven by the extra attention on the EV sector after Tesla's Q3 financial reports. Zapp recently announced a partnership with Younited SA to offer finance solutions ahead of its first i300 customer deliveries.

Portfolio Pulse from Erica Kollmann

October 19, 2023 | 2:55 pm

MDAI

Shares of Spectral AI Inc (NASDAQ:MDAI) are trading higher after the company announced that its DeepView SnapShot Wound Imaging System received Class 1 medical device classification with the FDA and was marked for use in the UK. The company now plans to seek regulatory approval for its DeepView AI - Burn software to commercialize the complete DeepView SnapShot System worldwide.

Portfolio Pulse from Adam Eckert

October 19, 2023 | 2:46 pm

MDAI

Spectral AI's shares are trading higher following the announcement that its DeepView SnapShot Wound Imaging System has been approved for use in the U.K. and received Class 1 medical device classification from the FDA.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 2:45 pm

APT

Aptos Network experienced a network outage that lasted for more than five hours during a mass drawing application to celebrate its one-year anniversary. The outage led to a rise in Aptos’s transaction fees and a temporary halt of deposits and withdrawals of Aptos Network tokens on cryptocurrency exchanges, Upbit and OKX. The price of the APT token dropped to its 24-hour low point during the outage but managed to recover afterwards.

Portfolio Pulse from Khyathi Dalal

October 19, 2023 | 2:27 pm

BMY

HALO

MRTX

Bristol Myers Squibb Co (BMY) has released positive topline data from a Phase 3 trial of a subcutaneous formulation of Opdivo for advanced kidney cancer. The formulation uses Halozyme Therapeutics Inc.'s (HALO) recombinant human hyaluronidase. The study met its primary and secondary endpoints. Earlier this month, BMY agreed to acquire Mirati Therapeutics Inc (MRTX) for $4.8 billion.

Portfolio Pulse from Vandana Singh

October 19, 2023 | 2:25 pm

SHEL

TTE

Shell PLC (NYSE:SHEL) has signed two long-term LNG sale and purchase agreements with affiliates of QatarEnergy for the supply of up to 3.5 million tons per annum (MTPA) of LNG from Qatar to the Netherlands. The LNG will be delivered to the Gate LNG terminal in the port of Rotterdam starting in 2026 for 27 years. The deal is similar to a TotalEnergies' (NYSE:TTE) deal last week with QatarEnergy to supply France. Both are Qatar's biggest and longest gas supply deals with Europe.

Portfolio Pulse from Nabaparna Bhattacharya

October 19, 2023 | 2:24 pm

GM

HMC

Honda Motor and General Motors have announced a partnership to launch a driverless taxi service in Japan. The automakers will form a joint venture in 2024 and launch the service in 2026 in central Tokyo. This service is expected to be the first of its kind in Japan, applying the level 4 autonomous driving standard to practical use on public roads.

Portfolio Pulse from Happy Mohamed

October 19, 2023 | 2:12 pm

ADIL

Adial Pharmaceuticals Inc (NASDAQ:ADIL) has been awarded a patent for combining its proprietary genetic diagnostic with its lead investigational product AD04, for the treatment of alcohol and opioid use disorders. The patent is seen as a significant milestone in the company's pursuit to provide more effective treatments. The company's shares are up 3.06% at $2.86.

Portfolio Pulse from Vandana Singh

October 19, 2023 | 2:00 pm

ADIL

Adial Pharmaceuticals has announced that its allowed claims cover the detection of select genotypes for the use of AD04 in treating Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD) patients.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 2:00 pm

ADIL

Adial Pharmaceuticals has been awarded a Notice of Allowance for a key patent that combines the use of the company's proprietary genetic diagnostic with AD04 to treat alcohol and drug dependence.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 1:59 pm